8 funkcijos, MB - financials and debts

Company age: 3 y. 5 mo.

Update

8 funkcijos - Company finances

EUR
2023
From: 2023-04-26
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue - 20,002 12,109
Profit before tax -4,952 -6,427 -5,351
Net profit -4,952 -6,427 -5,351
Equity -4,702 -10,979 -16,329
Liabilities 33,044 33,569 30,357
Non-current assets 25,892 15,157 7,477
Current assets 2,450 8,871 7,614
Total assets 28,342 24,028 15,091
Taxes paid
STI taxes 82 1,057 283
Financial indicators
Revenue change y/y - - -39.5%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -17.5% -26.7% -35.5%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - - -
Profit margin Net profit margin. Shows the overall profitability of the company. - -32.1% -44.2%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - -32.1% -44.2%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - - -
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - 20,002 14,128

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

8 funkcijos - Social security debts

From To Debt, €
2026-06-30 2026-07-31 846.09
2025-06-17 2025-07-15 0.01
2025-05-16 2025-06-04 0.01
2025-05-04 2025-05-11 0.01
2025-04-24 2025-04-29 0.01

8 funkcijos - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
8 funkcijos, MB (code 306305951) is a small partnership engaged in medical specialists activities. In 2025, the latest financial year, revenue decreased to €12.1K from €20.0K in 2024, representing a 39.5% decline. Net loss remained persistent at €5.4K in 2025, after a €6.4K loss in 2024 and a €5.0K loss in 2023. Profitability weakened further, with the 2025 profit margin at -44.2% versus -32.1% in 2024, indicating that losses absorbed a larger share of sales. Over the 2023–2025 period, the company has remained loss-making, while revenue reached its highest point in 2024 before falling in 2025. The balance sheet also contracted: total assets declined to €15.1K in 2025 from €24.0K in 2024 and €28.3K in 2023. Equity remained negative and widened to -€16.3K, while liabilities eased to €30.4K from €33.6K a year earlier. Long-term assets fell to €7.5K and short-term assets stood at €7.6K. Asset turnover was 0.80x in 2025.